Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance.
Gil-Núñez A, Masjuan J, Montaner J, Castellanos M, Segura T, Cardona P, Tembl JI, Purroy F, Arenillas J, Palacio E. Gil-Núñez A, et al. Among authors: cardona p. Neurologia (Engl Ed). 2022 Mar;37(2):136-150. doi: 10.1016/j.nrleng.2020.11.014. Epub 2021 Dec 11. Neurologia (Engl Ed). 2022. PMID: 34906541 Free article. Review.
Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores.
Purroy F, Jiménez Caballero PE, Gorospe A, Torres MJ, Alvarez-Sabin J, Santamarina E, Martínez-Sánchez P, Cánovas D, Freijo MM, Egido JA, Girón JM, Ramírez-Moreno JM, Alonso A, Rodríguez-Campello A, Casado I, Delgado-Medeiros R, Martí-Fàbregas J, Fuentes B, Silva Y, Quesada H, Cardona P, Morales A, de la Ossa N, García-Pastor A, Arenillas JF, Segura T, Jiménez C, Masjuán J; Stroke Project of the Spanish Cerebrovascular Diseases Study Group. Purroy F, et al. Among authors: cardona p. Cerebrovasc Dis. 2012;33(2):182-9. doi: 10.1159/000334771. Epub 2012 Jan 7. Cerebrovasc Dis. 2012. PMID: 22237056
Recurrent transient ischaemic attack and early risk of stroke: data from the PROMAPA study.
Purroy F, Jiménez Caballero PE, Gorospe A, Torres MJ, Alvarez-Sabin J, Santamarina E, Martínez-Sánchez P, Cánovas D, Freijo MJ, Egido JA, Ramírez-Moreno JM, Alonso-Arias A, Rodríguez-Campello A, Casado I, Delgado-Mederos R, Martí-Fàbregas J, Fuentes B, Silva Y, Quesada H, Cardona P, Morales A, de la Ossa NP, García-Pastor A, Arenillas JF, Segura T, Jiménez C, Masjuán J; Stroke Project of the Spanish Cerebrovascular Diseases Study Group. Purroy F, et al. Among authors: cardona p. J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):596-603. doi: 10.1136/jnnp-2012-304005. Epub 2013 Jan 23. J Neurol Neurosurg Psychiatry. 2013. PMID: 23345284
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial.
Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, Gállego J, Krupinski J, Gomis M, Cánovas D, Carné X, Deulofeu R, Román LS, Oleaga L, Torres F, Planas AM; URICO-ICTUS Investigators. Chamorro A, et al. Lancet Neurol. 2014 May;13(5):453-60. doi: 10.1016/S1474-4422(14)70054-7. Epub 2014 Apr 2. Lancet Neurol. 2014. PMID: 24703208 Clinical Trial.
How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up.
Purroy F, Jiménez Caballero PE, Gorospe A, Torres MJ, Alvarez-Sabin J, Martínez-Sánchez P, Cánovas D, Freijo M, Egido JA, Ramírez-Moreno JM, Alonso-Arias A, Rodríguez-Campello A, Casado-Naranjo I, Martí-Fàbregas J, Silva Y, Cardona P, Morales A, García-Pastor A, Arenillas JF, Segura T, Jiménez C, Masjuán J. Purroy F, et al. Among authors: cardona p. J Neurol. 2014 Aug;261(8):1614-21. doi: 10.1007/s00415-014-7390-z. Epub 2014 Jun 10. J Neurol. 2014. PMID: 24912470
Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.
Abilleira S, Ribera A, Dávalos A, Ribó M, Chamorro A, Cardona P, Molina CA, Martínez-Yélamos A, Urra X, Dorado L, Roquer J, Martí-Fàbregas J, Aja L, Tomasello A, Castaño C, Blasco J, Cánovas D, Castellanos M, Krupinski J, Guimaraens L, Perendreu J, Ustrell X, Purroy F, Gómez-Choco M, Baiges JJ, Cocho D, Saura J, Gallofré M; Catalan Stroke Code and Reperfusion Consortium. Abilleira S, et al. Among authors: cardona p. Cerebrovasc Dis. 2014;38(5):328-36. doi: 10.1159/000368433. Epub 2014 Nov 21. Cerebrovasc Dis. 2014. PMID: 25428822
Ischaemic stroke in patients treated with oral anticoagulants.
Cano LM, Cardona P, Quesada H, Lara B, Rubio F. Cano LM, et al. Among authors: cardona p. Neurologia. 2016 Jul-Aug;31(6):395-400. doi: 10.1016/j.nrl.2014.09.010. Epub 2014 Dec 16. Neurologia. 2016. PMID: 25529172 Free article. English, Spanish.
[Secondary prevention of ischemic non cardioembolic stroke].
Armario P, Pinto X, Soler C, Cardona P. Armario P, et al. Among authors: cardona p. Clin Investig Arterioscler. 2015 Nov-Dec;27(6):287-300. doi: 10.1016/j.arteri.2015.01.006. Epub 2015 Mar 12. Clin Investig Arterioscler. 2015. PMID: 25771074 Review. Spanish.
Factors associated with poor anticoagulation control with vitaminK antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study.
Contreras Muruaga MM, Reig G, Vivancos J, González A, Cardona P, Ramírez-Moreno JM, Martí-Fábregas J, Suárez Fernández C; en nombre de los investigadores del estudio ALADIN; Listado de investigadores del estudio ALADIN. Contreras Muruaga MM, et al. Among authors: cardona p. Rev Clin Esp (Barc). 2018 Oct;218(7):327-335. doi: 10.1016/j.rce.2018.04.020. Epub 2018 Jul 6. Rev Clin Esp (Barc). 2018. PMID: 29983190 English, Spanish.
301 results